Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 24 Breast Neoplasms 11 Prostatic Neoplasms 10 Colorectal Neoplasms 10 Hematologic Neoplasms 7 Ovarian Neoplasms 6 Lung Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Multiple Myeloma 4 Advanced Cancer 4 Uterine Cervical Neoplasms 3 Rectal Neoplasms 3 Lymphoma 3 Head and Neck Neoplasms 3 Gastrointestinal Neoplasms 3 Sarcoma 2 Peritoneal Neoplasms 2 Pain 2 Neoplasm Metastasis 2 Mouth Neoplasms 2 Melanoma 2 Low Anterior Resection Syndrome 2 Hematopoietic and Lymphoid System Neoplasm 2 Fatigue 2 Endometrial Neoplasms 2 Depression 2 Colorectal Neoplasms, Hereditary Nonpolyposis 2 Colonic Neoplasms 2 Brain Neoplasms 2 Bone Neoplasms 2

Interventions

pimodivir 1 Sunitinib 1 Rosuvastatin Calcium 1 Olive Oil 1 Midazolam 1 Interviews as Topic 1 Cyclosporine 1 Control Groups 1 Blood Specimen Collection 1 Adalimumab 1 (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Healthy × Interviews as Topic × Clear all

NCT02378363 2015-03-04

RISCOLAIRE

Institut de Cancérologie de la Loire

Healthy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡